Gene · 55
Papers3,704
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 3,704
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Environmental induced transgenerational inheritance impacts systems epigenetics in disease etiology. | Sci Rep | 2022 | 35440735 | PubTator, text mining | PubMed |
| Antisense Peptide Nucleic Acid-Diaminobutanoic Acid Dendron Conjugates with SbmA-Independent Antimicrobial Activity against Gram-Negative Bacteria. | ACS Infect Dis | 2022 | 35436109 | PubTator, text mining | PubMed |
| Glycoconjugate Nanoparticle-Based Systems in Cancer Immunotherapy: Novel Designs and Recent Updates. | Front Immunol | 2022 | 35432351 | PubTator, text mining | PubMed |
| Application of nanomaterials in proteomics-driven precision medicine. | Theranostics | 2022 | 35401834 | PubTator, text mining | PubMed |
| Using a Machine Learning Approach to Identify Key Biomarkers for Renal Clear Cell Carcinoma. | Int J Gen Med | 2022 | 35392028 | PubTator, text mining | PubMed |
| Evolution of Androgen Deprivation Therapy (ADT) and Its New Emerging Modalities in Prostate Cancer: An Update for Practicing Urologists, Clinicians and Medical Providers. | Res Rep Urol | 2022 | 35386270 | PubTator, text mining | PubMed |
| Association of TMPRSS2 Gene Polymorphisms with COVID-19 Severity and Mortality: a Case-Control Study with Computational Analyses. | Appl Biochem Biotechnol | 2022 | 35386063 | PubTator, text mining | PubMed |
| Selective estrogen receptor modulators contribute to prostate cancer treatment by regulating the tumor immune microenvironment. | J Immunother Cancer | 2022 | 35383112 | PubTator, text mining | PubMed |
| ADXS31142 Immunotherapy ± Pembrolizumab Treatment for Metastatic Castration-Resistant Prostate Cancer: Open-Label Phase I/II KEYNOTE-046 Study. | Oncologist | 2022 | 35373299 | PubTator, text mining | PubMed |
| Clinical and translational values of spatial transcriptomics. | Signal Transduct Target Ther | 2022 | 35365599 | PubTator, text mining | PubMed |
| Comparing Urinary Glycoproteins among Three Urogenital Cancers and Identifying Prostate Cancer-Specific Glycoproteins. | ACS Omega | 2022 | 35350332 | PubTator, text mining | PubMed |
| mRNA cancer vaccines: Advances, trends and challenges. | Acta Pharm Sin B | 2022 | 35345451 | PubTator, text mining | PubMed |
| Cancer Stem Cell Markers for Urinary Carcinoma. | Stem Cells Int | 2022 | 35342431 | PubTator, text mining | PubMed |
| Development of Peptide-Based Vaccines for Cancer. | J Oncol | 2022 | 35342400 | PubTator, text mining | PubMed |
| Genesis and Mechanism of Some Cancer Types and an Overview on the Role of Diet and Nutrition in Cancer Prevention. | Molecules | 2022 | 35335158 | PubTator, text mining | PubMed |
| Therapeutic Approaches Targeting Proteins in Tumor-Associated Macrophages and Their Applications in Cancers. | Biomolecules | 2022 | 35327584 | PubTator, text mining | PubMed |
| Advances in COVID-19 mRNA vaccine development. | Signal Transduct Target Ther | 2022 | 35322018 | PubTator, text mining | PubMed |
| Mitochondrial transport and metabolism of the vitamin B-derived cofactors thiamine pyrophosphate, coenzyme A, FAD and NAD+ , and related diseases: A review. | IUBMB Life | 2022 | 35304818 | PubTator, text mining | PubMed |
| A distinct core regulatory module enforces oncogene expression in KMT2A-rearranged leukemia. | Genes Dev | 2022 | 35301220 | PubTator, text mining | PubMed |
| Immunological Classification of Tumor Types and Advances in Precision Combination Immunotherapy. | Front Immunol | 2022 | 35296094 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55/papers?page=19